Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
Clinical trial NCT01909466 · COMPLETED
Trial details
- NCT number
- NCT01909466
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.